Applications of Artificial Intelligence in Medicine: A Comprehensive Systematic Review and Meta-Analysis
AROC in Pharmaceutical and Biotechnology · 2025
DOI: 10.53858/arocpb05030112 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift AROC in Pharmaceutical and Biotechnology, 2025. Verfasst von Bolaji Mubarak Ayeyemi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
The integration of Artificial Intelligence (AI) into medicine constitutes one of the most significant technological paradigm shifts in healthcare history. From the early rule-based expert systems of the 1970s to the current era of Deep Learning (DL) and Large Language Models (LLMs), AI has evolved to rival human performance in specific diagnostic tasks. This systematic review and meta-analysis aims to provide an exhaustive evaluation of AI applications across major medical specialties (Radiology, Pathology, Dermatology, Ophthalmology, Cardiology, Neurology, and Oncology), assess their diagnostic accuracy compared to clinical standards, and analyze the ethical, legal, and social implications of their widespread adoption.
Methods
We conducted a PRISMA-compliant systematic search across PubMed, Scopus, Web of Science, IEEE Xplore, and arXiv for studies published between 2010 and 2025. We utilized the QUADAS-2 tool for quality assessment of diagnostic accuracy studies and ROBINS-I for observational studies.
Results
A total of 4,250 records were screened, with 120 studies meeting the inclusion criteria for qualitative synthesis and 42 for quantitative meta-analysis. Deep learning models in radiology demonstrated a pooled sensitivity of 87% (95% CI: 85-89%) and specificity of 89% (95% CI: 87-91%). In dermatology, AI algorithms frequently outperformed general practitioners and performed on par with board-certified dermatologists in melanoma detection.
Conclusion
AI demonstrates robust diagnostic performance, particularly in image-intensive fields. However, the translation from “code to clinic” is hindered by algorithmic bias, lack of explainability, and regulatory uncertainty. Future efforts must focus on prospective, randomized clinical trials and the development of equitable, robust AI frameworks.
Zitieren
APA
Ayeyemi, B. M., Shobowale, K. O., Raji, R. O., & Abdulkabir, A. O. (2025). Applications of Artificial Intelligence in Medicine: A Comprehensive Systematic Review and Meta-Analysis. AROC in Pharmaceutical and Biotechnology. https://doi.org/10.53858/arocpb05030112
Vancouver
Ayeyemi BM, Shobowale KO, Raji RO, Abdulkabir AO. Applications of Artificial Intelligence in Medicine: A Comprehensive Systematic Review and Meta-Analysis. AROC in Pharmaceutical and Biotechnology. 2025. doi:10.53858/arocpb05030112
BibTeX
@article{Ayeyemi2025,
author = {Ayeyemi, Bolaji Mubarak and Shobowale, Karimot O. and Raji, Rofiyat Omolara and Abdulkabir, Aliyah Omotayo},
title = {Applications of Artificial Intelligence in Medicine: A Comprehensive Systematic Review and Meta-Analysis},
journal = {AROC in Pharmaceutical and Biotechnology},
year = {2025},
doi = {10.53858/arocpb05030112}
}
EUVIMED